Patient-Reported Outcome (PRO) Consortium translation process: consensus development of updated best practices

This paper describes the rationale and goals of the Patient-Reported Outcome (PRO) Consortium’s instrument translation process. The PRO Consortium has developed a number of novel PRO measures which are in the process of qualification by the U.S. Food and Drug Administration (FDA) for use in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Eremenco, Sonya, Pease, Sheryl, Mann, Sarah, Berry, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934912/
https://www.ncbi.nlm.nih.gov/pubmed/29757299
http://dx.doi.org/10.1186/s41687-018-0037-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934912/
https://www.ncbi.nlm.nih.gov/pubmed/29757299
http://dx.doi.org/10.1186/s41687-018-0037-6

Ejemplares similares